Bromide

Bromide

SCHEMBL5490738

Br.CCOc1cc2c(cc1C(=O)NC)C(=N)N(CC(=O)c1cc(N3CCOCC3)c(OS(C)(=O)=O)c(C(C)(C)C)c1)C2

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
F2R P25116 11/20 0.59
KDM4E B2RXH2 2/20 0.36
GAA P10253 1/20 0.34
ALDH1A1 P00352 4/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
MAPT P10636 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1731007 0.93 F2R (0.65) F2RKDM4EGAAALDH1A1L3MBTL1
Bromide SCHEMBL1729157 0.92 F2R (0.69) F2RKDM4EGAAALDH1A1L3MBTL1
SCHEMBL14449142 0.91 F2R (0.69) F2RKDM4EGAAALDH1A1L3MBTL1
Bromide SCHEMBL5491806 0.90 F2R (0.61) F2RKDM4EGAAALDH1A1L3MBTL1
Bromide SCHEMBL1729726 0.89 F2R (0.46) F2RKDM4ESMN1; SMN2MAPTLMNA
SCHEMBL1729310 0.88 F2R (0.60) F2RGAAALDH1A1L3MBTL1MEN1
Bromide SCHEMBL1731995 0.88 F2R (0.57) F2RKDM4EGAAALDH1A1L3MBTL1
Bromide SCHEMBL1729848 0.87 F2R (0.44) F2RKDM4EMAPT
Bromide SCHEMBL1729744 0.87 F2R (0.46) F2RKDM4EGAAALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL1729575 0.86 F2R (0.58) F2RGAAALDH1A1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7244730-B2 2-iminopyrrolidine derivatives EISAI CO., LTD (JP) 2007-07-17 US disclosed
US-20050245592-A1 2-Iminopyrrolidine derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-03 US disclosed
US-20050004204-A1 2-Iminopyrrolidine derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245592-A1 2-Iminopyrrolidine derivatives H1-2, H1-3, H1-0 F2R 2290/4885KDM4E 3161/4885GAA 4867/4885
US-20050004204-A1 2-Iminopyrrolidine derivatives H1-2, H1-3, H1-0 F2R 2289/4885KDM4E 3132/4885GAA 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.